Stanozolol in the Treatment of Pityriasis Rubra Pilaris

The document discussed the use of Stanozolol in treating Pityriasis Rubra Pilaris (PRP), a rare and distressing skin disease characterized by various symptoms including erythroderma, follicular papules, and hair loss. PRP could lead to painful fissuring and limitation of motion. Various treatments had been tried, including vitamin A, topical aminonicotinamide, azathioprine, methotrexate, isotretinoin, etretinate, PUVA, and systemic steroids, with anecdotal reports suggesting benefits from ascorbic acid or penicillin. The document reviewed the effects of these treatments and older remedies like arsenic and pilocarpine.